chr3-37050685-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000249.4(MLH1):​c.*32C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,543,852 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). The gene MLH1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.00082 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 9 hom. )

Consequence

MLH1
NM_000249.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 0.0580

Publications

1 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-37050685-C-T is Benign according to our data. Variant chr3-37050685-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 135561.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000817 (119/145662) while in subpopulation SAS AF = 0.00502 (24/4784). AF 95% confidence interval is 0.00346. There are 1 homozygotes in GnomAd4. There are 68 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.*32C>T
3_prime_UTR
Exon 19 of 19NP_000240.1P40692-1
MLH1
NM_001354628.2
c.*32C>T
3_prime_UTR
Exon 18 of 18NP_001341557.1A0A087WX20
MLH1
NM_001354629.2
c.*32C>T
3_prime_UTR
Exon 18 of 18NP_001341558.1A0AAQ5BGZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.*32C>T
3_prime_UTR
Exon 19 of 19ENSP00000231790.3P40692-1
MLH1
ENST00000456676.7
TSL:1
c.*32C>T
3_prime_UTR
Exon 17 of 17ENSP00000416687.3H0Y818
MLH1
ENST00000413740.2
TSL:1
c.*32C>T
3_prime_UTR
Exon 15 of 15ENSP00000416476.2H0Y806

Frequencies

GnomAD3 genomes
AF:
0.000824
AC:
120
AN:
145564
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000748
Gnomad ASJ
AF:
0.00711
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00501
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0201
Gnomad NFE
AF:
0.000689
Gnomad OTH
AF:
0.00100
GnomAD2 exomes
AF:
0.00158
AC:
395
AN:
250380
AF XY:
0.00180
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00107
Gnomad ASJ exome
AF:
0.00625
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000916
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00110
AC:
1537
AN:
1398190
Hom.:
9
Cov.:
27
AF XY:
0.00128
AC XY:
893
AN XY:
696698
show subpopulations
African (AFR)
AF:
0.000128
AC:
4
AN:
31256
American (AMR)
AF:
0.00117
AC:
51
AN:
43758
Ashkenazi Jewish (ASJ)
AF:
0.00580
AC:
148
AN:
25526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39616
South Asian (SAS)
AF:
0.00616
AC:
523
AN:
84952
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49766
Middle Eastern (MID)
AF:
0.00419
AC:
22
AN:
5256
European-Non Finnish (NFE)
AF:
0.000664
AC:
704
AN:
1060110
Other (OTH)
AF:
0.00147
AC:
85
AN:
57950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
78
156
235
313
391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000817
AC:
119
AN:
145662
Hom.:
1
Cov.:
32
AF XY:
0.000955
AC XY:
68
AN XY:
71238
show subpopulations
African (AFR)
AF:
0.000179
AC:
7
AN:
39032
American (AMR)
AF:
0.000747
AC:
11
AN:
14718
Ashkenazi Jewish (ASJ)
AF:
0.00711
AC:
24
AN:
3374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00502
AC:
24
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10080
Middle Eastern (MID)
AF:
0.0216
AC:
6
AN:
278
European-Non Finnish (NFE)
AF:
0.000689
AC:
45
AN:
65346
Other (OTH)
AF:
0.000993
AC:
2
AN:
2014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000750
Hom.:
0
Bravo
AF:
0.000820

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Colorectal cancer, hereditary nonpolyposis, type 2 (1)
-
-
1
not provided (1)
-
-
1
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.3
DANN
Benign
0.65
PhyloP100
0.058
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200903126; hg19: chr3-37092176; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.